Discover 4,573 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,573
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
for
Neuroblastoma, Pheochromocytoma
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 1+
Code: NCT00107289
Phase 2, Recruiting
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
for
Parkinson Disease
Location: New York NY
Sponsor: Teachers College, Columbia University
Sex: All
Age: 50 - 70+
Code: NCT06540989
Early Phase 1, Recruiting
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
for
DLBCL
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT03758989
Phase 2, Recruiting
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
for
Glioblastoma, Gliosarcoma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06934889
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
for
Intrahepatic Cholangiocarcinoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT04891289
Phase 2, Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies